Related Articles
Antisense oligonucleotide targeted to RIα subunit of cAMP-dependent protein kinase (GEM231) enhances therapeutic effectiveness of cancer chemotherapeutic agent irinotecan in nude mice bearing human cancer xenografts: in vivo synergistic activity, pharmacokinetics and host toxicity
MDM2 oncogene as a target for cancer therapy: An antisense approach.
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides
Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene
Induction of cell arrest by transfection of macrophage migration inhibitory factor antisense plasmid